Literature DB >> 2478725

An assessment of the current use of human interferons in therapy of urological cancers.

J S Horoszewicz1, G P Murphy.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2478725     DOI： 10.1016/s0022-5347(17)39022-5

Source DB:  PubMed          Journal:  J Urol        ISSN： 0022-5347            Impact factor:   7.450


× No keyword cloud information.
  22 in total

1.  Cytokines and cancer.

Authors:  S Malik; J Waxman
Journal:  BMJ       Date:  1992-08-01

2.  Sinonasal Metastatic Renal Cell Carcinoma: A Report of Two Cases with Varied Presentation and a Review of Literature.

Authors:  Pooja Dalakoti; Kailesh Pujary; Balakrishnan Ramaswamy
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2018-08-24

3.  In vitro drug sensitivity testing of human testicular germ cell tumours with cytostatic drugs and interferon alpha-2b.

Authors:  B Küpeli; S Baltaci; M Beksac; O Süzer; S Küpeli; O Göğüs
Journal:  Int Urol Nephrol       Date:  1997       Impact factor: 2.370

4.  Pharmacokinetics of recombinant interferon alpha-C.

Authors:  O Merimsky; M Rubinstein; D Fischer; A Danon; S Chaitchik
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333

Review 5.  Rationale for immunotherapy of renal cell carcinoma.

Authors:  R Heicappell; R Ackermann
Journal:  Urol Res       Date:  1990

Review 6.  Perspectives in drug development for metastatic renal cell cancer.

Authors:  Bristi Basu; Tim Eisen
Journal:  Target Oncol       Date:  2010-08-06       Impact factor: 4.493

7.  Cytotoxic effects of alpha- and gamma-interferon and tumor necrosis factor in human bladder tumor cell lines.

Authors:  H B Niell; A M Mauer; D Rademacher
Journal:  Urol Res       Date:  1994

8.  Prospective randomized trial of natural interferon-alpha versus natural interferon-alpha plus cimetidine in advanced renal cell carcinoma with pulmonary metastasis.

Authors:  Toshiaki Kinouchi; Junichi Sakamoto; Taiji Tsukamoto; Hideyuki Akaza; Yoshinobu Kubota; Seiichiro Ozono; Hiroshi Kanetake; Tetsuo Taguchi; Toshihiko Kotake
Journal:  J Cancer Res Clin Oncol       Date:  2006-04-04       Impact factor: 4.553

9.  Interferon beta enhances the natural killer activity of patients with bladder carcinoma.

Authors:  L Moltó; J Carballido; L Manzano; C Olivier; P Lapeña; M Alvarez-Mon
Journal:  Cancer Immunol Immunother       Date:  1994-06       Impact factor: 6.968

10.  Induction of tumour necrosis factor-alpha (TNF-alpha) mRNA in bladders and spleens of mice after intravesical administration of bacillus Calmette-Guérin.

Authors:  J S Shin; J H Park; J D Kim; J M Lee; S J Kim
Journal:  Clin Exp Immunol       Date:  1995-04       Impact factor: 4.330
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.